- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
3
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
3 companies
NATCO Pharma
Market Cap: ₹153.8b
A pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally.
NATCOPHARM
₹858.95
7D
-0.4%
1Y
-15.4%
Jenburkt Pharmaceuticals
Market Cap: ₹5.7b
Researches and develops, manufactures, and markets pharmaceutical and healthcare products in India.
524731
₹1,294.60
7D
11.0%
1Y
64.9%
Gennex Laboratories
Market Cap: ₹3.0b
Engages in manufacturing and selling of bulk drugs, intermediates, and biotech products.
531739
₹13.04
7D
-6.4%
1Y
-16.5%